Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 110

Sort by

Sort Order Select

Journal Articles

Anticoagulation management and outcomes in cancer-associated ovarian and renal vein thrombosis: A multicenter retrospective cohort study

Elena Butera, Chiara Cavallaro, Alessandro D'Errico, Rosa Talerico, Ranjeeta Mallick, Roger Kou, Marc Carrier, Roberto Pola, Tzu-Fei Wang

Blood (2025) 146 (Supplement 1): 4906.

https://doi.org/10.1182/blood-2025-4906

Published: 2025

Journal Articles

Incidence of thrombosis and bleeding in patients receiving CAR-T cell therapy: A multicentric retrospective analysis of the Canadian experience

Luciana Melo Garcia, Tzu-Fei Wang, Michael Kennah, Abdullah Alanazi, Sarah Mckeague, John Kuruvilla, Inna Gong, Naomi Marali Xiao, Christopher Lemieux, Camille Sylvestre, Amaris Balitsky, Isabelle Fleury, Mathias Castonguay, Robert Puckrin, Hannah Cherniawsky, Amani Ahmed, Mahmoud Elsawy, Maggie McGuire, Miriam Kimpton

Blood (2025) 146 (Supplement 1): 4496.

https://doi.org/10.1182/blood-2025-4496

Published: 2025

Journal Articles

Impact of concurrent antiplatelet/NSAID use on the safety and efficacy of thromboprophylaxis with apixaban in patients with cancer: A post-hoc analysis of the AVERT trial

Mysa Saad, Ranjeeta Mallick, Danny Hill, Alejandro Lazo-Langner, Vicky Tagalakis, Tzu-Fei Wang, Philip S. Wells, Marc Carrier

Blood (2025) 146 (Supplement 1): 741.

https://doi.org/10.1182/blood-2025-741

Published: 2025

Journal Articles

Low-dose chemotherapy for induction in pediatric AML: Retrospective outcome analysis across expanded cohorts

Blood (2025) 146 (Supplement 1): 1661.

https://doi.org/10.1182/blood-2025-1661

Published: 2025

Journal Articles

Clonal timing of FLT3-ITD dictates evolutionary trajectory and phenotypic heterogeneity in acute myeloid leukemia

Xu-Dong He, Mengfang Xia, Ruoyang Shao, Qifa Liu, Qian-Fei Wang

Blood (2025) 146 (Supplement 1): 988.

https://doi.org/10.1182/blood-2025-988

Published: 2025

Journal Articles

Outcomes and resource utilization during and after oral anticoagulant-related bleeding in chronic kidney disease (ORACLE-CKD): A population-based cohort study

Alexa Moschella, Manish Sood, David Kirkwood, J. Michael Paterson, Tzu-Fei Wang, Rinku Sutradhar, Deborah Siegal

Blood (2025) 146 (Supplement 1): 950.

https://doi.org/10.1182/blood-2025-950

Published: 2025

Journal Articles

Comprehensive profiling of highly heterogeneous FLT3-ITD variants reveals distinct drug response patterns in AML

Zhenyi Yi, Aili Chen, Lina Yan, Qiyi Chen, Hong-Hu Zhu, Qian-Fei Wang

Blood (2025) 146 (Supplement 1): 641.

https://doi.org/10.1182/blood-2025-641

Published: 2025

Journal Articles

Allograft inflammatory factor -1 is essential for acute monocytic leukemia infiltration

Aili Chen, Haiyang Hu, Hong-Hu Zhu, Gang Huang, Qian-Fei Wang

Blood (2025) 146 (Supplement 1): 5255.

https://doi.org/10.1182/blood-2025-5255

Published: 2025

Journal Articles

Impact of race on the incidence, diagnosis and outcomes of pregnancy-associated venous thromboembolism: A nested case-control study

Yan Xu, Michael Pugliese, Leslie Skeith, Manish Sood, A. Kinga Malinowski, Steven Hawken, Isabelle Malhamé, Jude Mary Cénat, Tzu-Fei Wang, Jerome Federspiel, Marc Carrier

Blood (2025) 146 (Supplement 1): 1340.

https://doi.org/10.1182/blood-2025-1340

Published: 2025

Journal Articles

Multicenter prospective Phase II study of decitabine priming combined with low-dose idarubicin, cytarabine, and G-CSF in children with refractory or relapsed Acute Myeloid Leukemia

Blood (2025) 146 (Supplement 1): 5233.

https://doi.org/10.1182/blood-2025-5233

Published: 2025

Journal Articles

Development and validation of a weighted cytokine scoring system for immune status Assessment Following CD19 CAR-T Therapy

Dongchu Wang, Fei Wang, Hui Wang

Blood (2025) 146 (Supplement 1): 5141.

https://doi.org/10.1182/blood-2025-5141

Published: 2025

Journal Articles

The endothelial mTORC2-Foxo1 axis serves as an iron-responsive sensor governing systemic iron homeostasis

Blood (2025) 146 (14): 1722–1736.

https://doi.org/10.1182/blood.2025028454

Published: 2025

Includes: Supplemental data

Journal Articles

Performance Status, Cancer-Associated Thrombosis, and Bleeding: A Post-Hoc Analysis of the Avert Trial

Nicola Potere, Ranjeeta Mallick, Yan Xu, Tzu-Fei Wang, Philip Stephen Wells, Marc Carrier

Blood (2024) 144 (Supplement 1): 4018.

https://doi.org/10.1182/blood-2024-210101

Published: 2024

Journal Articles

Management of Upper Extremity Superficial Vein Thrombosis in Patients with Cancer: A Retrospective Observational Cohort Study

Lauren Tokessy, Cameron Brown, Tzu-Fei Wang, Miriam Kimpton, Marc Carrier

Blood (2024) 144 (Supplement 1): 2630.

https://doi.org/10.1182/blood-2024-211811

Published: 2024

Journal Articles

Targeted Therapy with CX4945 Biomimetic Nanodrug Delivery System for High-Risk B-Cell Acute Lymphoblastic Leukemia

Yan Wang, Fei Wang, Haoan Wu, Qi Han, Yu Zhang, Chunhua Song, Zheng Ge

Blood (2024) 144 (Supplement 1): 2788.

https://doi.org/10.1182/blood-2024-202461

Published: 2024

Journal Articles

Outcomes of Children and Adolescents with Acute Myeloid Leukemia and KIT Mutations Treated with Low- or Standard-Dose Chemotherapy Plus Dasatinib on the CALSⅢ-AML18 Trial

Yixin Hu, Xiuli Ju, Yunyan He, Ningling Wang, Xiaowen Zhai, Yufeng Liu, Hua Jiang, Hongjun Liu, Liangchun Yang, Minghua Yang, Jixia Luo, Qi An, Xiaojun Yuan, Qian-Fei Wang, Raul C. Ribeiro, Shaoyan Hu

Blood (2024) 144 (Supplement 1): 6050.

https://doi.org/10.1182/blood-2024-211911

Published: 2024

Journal Articles

Outcomes of Children and Adolescents with Acute Myeloid Leukemia and FLT3-ITD Treated with Low- or Standard-Dose Chemotherapy Plus Sorafenib on the Cals III-AML18 Trial (ChiCTR1800015883)

Li Gao, Hua Jiang, Xiuli Ju, Yunyan He, Hongjun Liu, Xiaowen Zhai, Ningling Wang, Minghua Yang, Jixia Luo, Yufeng Liu, Liangchun Yang, Qi An, Xiaojun Yuan, Qian-Fei Wang, Raul C. Ribeiro, Shaoyan Hu

Blood (2024) 144 (Supplement 1): 6049.

https://doi.org/10.1182/blood-2024-211113

Published: 2024

Journal Articles

Imaging Predictors of Intracerebral Hemorrhage in Patients with Brain Tumors Treated with Anticoagulation

Blood (2024) 144 (Supplement 1): 1246.

https://doi.org/10.1182/blood-2024-199172

Published: 2024

Journal Articles

FLT3-ITD Mutation Expands HSPC Compartment to Initiate AML Development

Mengfang Xia, Xu-Dong He, Ruoyang Shao, Qifa Liu, Qian-Fei Wang

Blood (2024) 144 (Supplement 1): 2915.

https://doi.org/10.1182/blood-2024-204909

Published: 2024

Journal Articles

Trials in Progress: The START (STrategies for Anticoagulation in patients with thRombocytopenia and cancer-associated Thrombosis) Pilot Randomized Controlled Trial

Tzu-Fei Wang, Mari Thomas, Avi Leader, Andrea Lee Cervi, Cynthia M. Wu, Simon J Stanworth, Marc Carrier

Blood (2024) 144 (Supplement 1): 5553.

https://doi.org/10.1182/blood-2024-207194

Published: 2024

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Anticoagulation management and outcomes in cancer-associated ovarian and renal vein thrombosis: A multicenter retrospective cohort study

Incidence of thrombosis and bleeding in patients receiving CAR-T cell therapy: A multicentric retrospective analysis of the Canadian experience

Impact of concurrent antiplatelet/NSAID use on the safety and efficacy of thromboprophylaxis with apixaban in patients with cancer: A post-hoc analysis of the AVERT trial

Low-dose chemotherapy for induction in pediatric AML: Retrospective outcome analysis across expanded cohorts

Clonal timing of FLT3-ITD dictates evolutionary trajectory and phenotypic heterogeneity in acute myeloid leukemia

Outcomes and resource utilization during and after oral anticoagulant-related bleeding in chronic kidney disease (ORACLE-CKD): A population-based cohort study

Comprehensive profiling of highly heterogeneous FLT3-ITD variants reveals distinct drug response patterns in AML

Allograft inflammatory factor -1 is essential for acute monocytic leukemia infiltration

Impact of race on the incidence, diagnosis and outcomes of pregnancy-associated venous thromboembolism: A nested case-control study

Multicenter prospective Phase II study of decitabine priming combined with low-dose idarubicin, cytarabine, and G-CSF in children with refractory or relapsed Acute Myeloid Leukemia

Development and validation of a weighted cytokine scoring system for immune status Assessment Following CD19 CAR-T Therapy

The endothelial mTORC2-Foxo1 axis serves as an iron-responsive sensor governing systemic iron homeostasis

Performance Status, Cancer-Associated Thrombosis, and Bleeding: A Post-Hoc Analysis of the Avert Trial

Management of Upper Extremity Superficial Vein Thrombosis in Patients with Cancer: A Retrospective Observational Cohort Study

Targeted Therapy with CX4945 Biomimetic Nanodrug Delivery System for High-Risk B-Cell Acute Lymphoblastic Leukemia

Outcomes of Children and Adolescents with Acute Myeloid Leukemia and KIT Mutations Treated with Low- or Standard-Dose Chemotherapy Plus Dasatinib on the CALSⅢ-AML18 Trial

Outcomes of Children and Adolescents with Acute Myeloid Leukemia and FLT3-ITD Treated with Low- or Standard-Dose Chemotherapy Plus Sorafenib on the Cals III-AML18 Trial (ChiCTR1800015883)

Imaging Predictors of Intracerebral Hemorrhage in Patients with Brain Tumors Treated with Anticoagulation

FLT3-ITD Mutation Expands HSPC Compartment to Initiate AML Development

Trials in Progress: The START (STrategies for Anticoagulation in patients with thRombocytopenia and cancer-associated Thrombosis) Pilot Randomized Controlled Trial

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only